SlideShare a Scribd company logo
Acute diarrhea
Cristina Olariu, MD, PhD
Assistant Professor at University of Medicine and Pharmacy Carol Davila
National Institute for Infectious Diseases “Prof. Dr. Matei Bals”
Agenda
• Definitions, pathophysiological mechanisms
• Diagnostic strategies
• Diagnostic algorithm
Definition
= increased stool frequency, liquidity or volume
1increase in stool frequency;
2passage of loose stools.
3Diarrhea is objectively defined as passing a stool
weight or volume greater than 200 g or 200 mL
per 24 hours.
• Diarrhea is a major cause of morbidity. It is important to recognize
that diarrhea is a symptom or sign, not a disease, and can be caused
by numerous conditions.
• An understanding of the basic mechanisms of diarrhea can help
facilitate diagnosis and management.
Defense mechanisms
1. Gastric acid secretion (pH < 4 → > 90% of bacteria are
destroyed in one hour)
2. Normal enteric flora
- superior IS (alkaline pH, richly vascularized mucosa) → systemic
absorption of toxins (enterococci, BGN)
- terminal ileum, colon (> 99% anaerobic flora, species specificity,
individual, stable)
1. Gastrointestinal and colonic motility (eg Shigella and
Salmonella treated with antidiarrheals → worsening)
2. Phagocytosis and humoral and cellular immunity
3. Other defense mechanisms:
- genetic determinants
- infants: lactoferrin, lysozyme, oligosaccharides
Pathogenic mechanisms
1. Inoculum size
2. Accelerating intestinal transit
3. Adhesion of bacteria to the intestinal mucosa
4. The ability to "invade" the intestinal mucosa
5. Toxin production:
- endotoxins (lipopolysaccharides)
- exotoxins (polypeptides)
6. Bacterial translocation
1. Size of inoculum
• 10-100 bacteria / cysts
- Shigella, E. Coli, G. Lamblia, Entamoeba hystolitica;
- direct contact, person to person
• 105- 108- V. cholerae
2. Accelerating intestinal transit
→ Reduces contact time with the intestinal mucosa
→ Cancels the dominance of colonic anaerobes
Causes secretory and osmotic diarrhea
*Slowing of intestinal transit → Secretory D. by SIBO
3. Adhesion of bacteria to the intestinal
mucosa
• Adhesion factors = plasmidally encoded Ag
• Fimbrii, pili, flageli
• Microbial molecules involved in adhesion and
fixation - adhesives
4. The ability to invade the intestinal
mucosa
= Synthesis (plasmid coding) of:
- adhesins
- cytotoxic exotoxins (Shigella, Cl., Staf)
- integrins → survival and multiplication of germs in
the intestinal epithelial cells (Salmonella, Shigella)
Toxin production
Enterotoxins Cytotoxins Neurotoxins
Secretory
= watery D.
Toxin of V. cholerae
Enterotoxigenic E.coli :
- heat labile enterotoxins (LT)
- heat-stable enterotoxins (ST)
Infectious D
Staf. aureus
Bacillus cereus
Shigella dysentarie tip 1
Vibrio parahaemolyticus
Cl. Difficile
E.Coli enterohemoragică
5. Bacterial translocation
• the bacterial passage from the intestinal lumen
• passage of endotoxins through the intact intestinal barrier
Intestinal barrier:
→ extrinsic: mucus, IgA, intestinal flora
→ intrinsic: - transcellular (intestinal cells)
- paracellular ("tight" junction)
Pathophysiology
Incomplete absorption of water from intestinal luminal
contents
• Water itself is not actively transported across the intestinal
mucosa but moves across secondary to osmotic forces
generated by the transport of solutes, such as electrolytes
and nutrients.
• Normally, absorption and secretion take place
simultaneously, but absorption is quantitatively greater
Either a decrease in absorption or an increase in secretion leads to
additional water within the lumen and diarrhea(Excess stool water
then causes decreased stool consistency)
Normally, SI and LI absorb 99% of the fluids. Therefore, even a very small reduction (eg 1%) in absorption or an
increase in secretion causes an increase in water content sufficient to cause diarrhea.
Pathophysiologic mechanisms
• Osmotic diarrhea
= involves an unabsorbed substance that draws water from the plasma
into the intestinal lumen along osmotic gradients
• Secretory diarrhea
= results from disordered electrolyte transport and, despite the term,
is more commonly caused by decreased absorption rather than net
secretion.
• Inflammatory
Inflammatory diseases cause diarrhea with exudative, secretory, or
osmotic components
• Altered motility
= may alter fluid absorption by increasing or decreasing the exposure
of luminal content to intestinal absorptive surface.
However, from a pathophysiologic perspective, no single cause of
diarrhea is truly unifactorial.
Diagnostic strategy
An understanding of the epidemiological settings in which diarrhea
occurs (eg, community acquired, hospital acquired, or travel
related) will also help direct diagnosis and treatment.
Physical
examination
Detailed
history
Simplified 5-Step Approach
1. Does the patient really have diarrhea? Beware of fecal
incontinence and impaction!
2. Rule out medications as a cause of diarrhea (drug-
induced diarrhea).
3. Distinguish acute from chronic diarrhea.
4. Categorize the diarrhea as inflammatory, fatty, or
watery.
5. Consider factitious diarrhea
1. Does the Patient Really Have Diarrhea?
Beware of Fecal Incontinence and Impaction
• Fecal incontinence is often reported as diarrhea because of embarrassment
associated with this condition rather than because the patient has any real
difficulty distinguishing diarrhea from incontinence
- direct questioning and assessment of anal squeeze on digital examination!
Incontinence is defined as the involuntary release of rectal contents; continence
requires intact anorectal structure and neuromuscular function; although many
incontinent patients have loose stools, their predominant problem is anal
sphincter dysfunction and not dysregulated intestinal fluid or electrolyte
absorption
If fecal incontinence is frequent, especially if it occurs in the absence of rectal urgency
or loose stools, the patient should be evaluated for incontinence and not diarrhea.
• Fecal impaction
- Patients with chronic constipation may develop fecal impaction from the inability to
expel a large fecal mass through the anus; rectal distention causes relaxation of
the internal anal sphincter, and there is induction of secretions proximal to the
obstructing stool→ An overflow diarrhea results from liquid stool passing around
the impaction and may be reported as diarrhea
- A careful rectal examination will allow identification and treatment of this condition.
2. Rule Out Medications as a Cause of Diarrhea
(Drug-Induced Diarrhea)
The key to diagnosing drug-induced diarrhea is to establish the
temporal relationship between starting use of the drug and
onset of diarrhea
• The medications that most frequently cause
diarrhea:
- antacids and nutritional supplements that contain
magnesium
- antibiotics
- proton pump inhibitors
- selective serotonin reuptake inhibitors
- nonsteroidal anti-inflammatory drugs.
2. Drug-induced diarrhea
• activation of specific receptors and transporters
• alteration in colonic bacterial flora
• changes in mesenteric blood flow
• provocation of intestinal inflammation
• apoptotic enteropathy
• Caffeine is an agent that may cause increased intestinal fluid secretion by elevating intracellular
cyclic adenosine monophosphate levels
• Antibiotics alter colonic bacterial flora that may then decrease colonic bacterial fermentation of
malabsorbed carbohydrates or lead to Clostridium difficile infection
• Mesenteric vasoconstricting agents may decrease mesenteric blood flow and cause malabsorption
• Nonsteroidal anti-inflammatory drugs or mycophenolate mofetil are agents that may incite
intestinal inflammation, causing diarrhea
• chemotherapy may cause intestinal or colonic crypt damage, thus impairing water absorption and
resulting in an apoptotic enterocolopathy
To identify drug-induced diarrhea, it is imperative that the physician take a complete medication
history and inquire about over-the-counter medications and supplements (eg, vitamin C and
magnesium). Treatment involves withdrawal of the offending drug.
3. Distinguish acute from chronic diarrhea
• acute if it lasts fewer than 2 weeks
it is most commonly caused by infection and is self-limited
often, no evaluation or treatment is required.
• chronic if it lasts more than 4 weeks
• stool testing and other studies are often indicated in the presence
of certain clinical or epidemiological features, including age older
than 65 years, immune compromise, volume depletion,
hematochezia or blood-tinged stool, fever, severe abdominal pain,
recent antibiotic use, known or suspected inflammatory bowel
disease, community infectious disease outbreaks, and employment
as a food handler. In contrast to acute diarrhea, chronic diarrhea
typically warrants a diagnostic evaluation, is less likely to resolve on
its own, and presents a broad differential diagnosis.
Epidemiological features
• Traveler’s diarrhea:
- bacterial infections;
- parasitosis
- tropical sprue
• Epidemics:
- bacterial infections;
- viral infections;
- inf. with protozoa (Cryptosporidium)
- idiopathic epidemic secretory diarrhea
• Patients with HIV / AIDS:
- opportunistic infections (CMV, Mycobacterium avium)
- AE of ARV medication
- lymphoma
• Institutionalized patients:
- colitis with Cl. Difficile
- intoxications / drug RA / artificial feeding / false diarrhea
• Patients with diabetes:
- impaired motility
- AE of medication (Metformin)
- associated diseases (celiac disease, exocrine pancreatic insufficiency)
Indications for evaluation
• Dehydration/ volume depletion
• hematochezia or blood-tinged stool
• Fever ≥ 38.5˚C
• Duration> 48h without improvement
• Recent antibiotic use
• Associated severe abdominal pain
• Age ≥ 65- 70 years
• Immunocompromised patients
Categorization of diarrhea. CT = computed tomography; EUS = endoscopic ultrasonography; SIBO = small intestinal bacterial overgrowth.
4. Categorize the diarrhea as inflammatory, fatty, or watery
Inflammatory diarrhea
• frequent, small-volume, bloody stools and may be accompanied by tenesmus, fever,
or severe abdominal pain
• leukocytes or leukocyte proteins (eg, calprotectin or lactoferrin) on stool
examination
• elevated C-reactive protein level or sedimentation rate and low serum albumin level
Inflammatory diarrhea fundamentally indicates disrupted and inflamed mucosa:
- idiopathic inflammatory bowel disease (Crohn disease or ulcerative colitis)
- ischemic colitis
- infectious processes, such as C difficile, cytomegalovirus, tuberculosis,
or Entamoeba histolytica
- Radiation colitis and neoplasia
When history or stool analysis suggests chronic inflammatory diarrhea, flexible
sigmoidoscopy or colonoscopy should be the initial study to look for structural
changes.
Fatty stools
• weight loss, greasy or bulky stools that are difficult to flush, and oil in the toilet bowl that requires a brush to
remove
• The basic mechanisms of chronic fatty diarrhea are malabsorption and maldigestion;
- Fat malabsorption results from inadequate mucosal transport;
- Fat maldigestion results from defective hydrolysis of triglycerides
Malabsorption is caused by mucosal diseases, most commonly celiac disease, whereas the maldigestion results from
pancreatic exocrine insufficiency (eg, chronic pancreatitis) or inadequate duodenal bile acid concentration (eg,
small intestinal bacterial overgrowth [SIBO] or cirrhosis)
A simple test to screen for excess fecal fat is a Sudan stain, which will detect most cases of clinically significant
steatorrhea. However, the criterion standard for steatorrhea is a quantitative measurement on a timed stool
collection while patients consume a 100-g fat diet, and steatorrhea is defined as more than 7 g of fat per 24
hours.
When fatty diarrhea is identified, the initial goal is to distinguish malabsorption from maldigestion
- Endoscopy with small bowel biopsies allows evaluation of the small intestinal mucosa for celiac disease.
- Small bowel aspiration can be performed to look for SIBO, which causes steatorrhea by deconjugation of
bile acids with resultant low duodenal bile acid concentrations. In addition,
- Hydrogen breath tests may be used to diagnose SIBO
The diagnosis of SIBO requires consideration of a predisposing factor, such as intestinal stasis, achlorhydria, pancreatic
insufficiency, or immune deficiency
If small bowel disease is excluded, computed tomography or endoscopic ultrasonography may be useful to identify
morphological changes of chronic pancreatitis
If no intestinal abnormalities are found and there is no evidence of chronic pancreatitis, abnormal pancreatic exocrine
function should be considered. An empiric trial of pancreatic enzyme supplementation may be used to assess for
the presence of pancreatic exocrine insufficiency - high doses of enzymes should be prescribed, and some
objective measurement, such as fecal fat excretion or weight gain, should be monitored to assess response
Watery diarrhea→ osmotic or secretory in origin
• Osmotic diarrhea is due to the ingestion of poorly absorbed ions or sugars
• Secretory diarrhea is due to disruption of epithelial electrolyte transport.
Two ways to distinguish an osmotic from a secretory process is by response
to fasting and calculating the fecal osmotic gap:
- An essential characteristic of osmotic diarrhea is that stool volume
decreases with fasting, whereas secretory diarrhea typically continues
unabated with fasting
- Another way to clinically differentiate osmotic diarrhea from
secretory diarrhea is by calculating the fecal osmotic gap:
• A fecal osmotic gap greater than 50 mmol/L suggests an osmotic cause for
diarrhea
• A gap less than 50 mmol/L supports a secretory origin
Fecal osmotic gap
Osmotic diarrhea
• poorly absorbed cations (eg, magnesium) or anions
(eg, phosphate, or sulfate)↔laxatives and antacids
• carbohydrate malabsorption from ingestion of poorly
absorbed sugars or sugar alcohols (eg, sorbitol or
xylitol)
• Lactose intolerance is by far the most common type of
carbohydrate malabsorption, with prevalence rates up
to 100% in Africa, Asia, and Latin America
Measuring a stool pH can help distinguish between osmotic diarrhea due to
poorly absorbed ions and that due to poorly absorbed sugars
• Carbohydrate malabsorption will result in a stool
pH less than 6 because as carbohydrates reach the
colon they are fermented by bacteria, releasing
short-chain fatty acids and making the stool water
acidic
• Lactase is present in IS in most young, immature
mammals but decreases or disappears at
adulthood →70% of adults have lactase deficiency
• The basic pathophysiologic mechanism
involves either net secretion of ions (chloride
or bicarbonate) or inhibition of net sodium
absorption
• The most common cause of secretory diarrhea
is infectious; however, infection is an
uncommon cause of chronic secretory
diarrhea. Therefore, noninfectious causes of
secretory diarrhea should be sought.
Major Causes of Secretory Diarrhea
• Infection
• Bile acid malabsorption
• Nonosmotic laxatives
• Inflammatory bowel disease (microscopic colitis, Crohn
disease, ulcerative colitis)
• Disordered regulation (eg, post vagatomy, diabetic
neuropathy)
• Peptide-secreting endocrine tumors
• Neoplasia (colon carcinoma, lymphoma, villous
adenoma)
• Idiopathic or epidemic secretory diarrhea
Tumor Associated findings
Gastrinoma Abdominal pain, erosive esophagitis, enlarged
gastric folds, duodenal ulcers
Carcinoid Flushing, enlarged nodular liver from metastases
VIPoma Hypokalemia, achlorhydria
Somatostatinoma Diabetes mellitus, cholelithiasis, hypochlorhydria
Glucagonoma Diabetes mellitus, deep vein thrombosis,
depression, necrolytic migratory erythema
Endocrine Neoplasms Associated With Diarrhea
5. Consider Factitious Diarrhea
• Factitious diarrhea is an intentionally self-inflicted disorder. The
most frequent cause of factitious diarrhea is surreptitious laxative
ingestion(up to 15% of patients who undergo an evaluation for
chronic diarrhea may be surreptitiously ingesting laxatives)
• Individuals with factitious diarrhea are most commonly women of
higher socioeconomic status and often employed in the medical
field. There is frequently a history of multiple medical consultations
or hospitalizations in an effort to establish the cause of diarrhea
• Evaluation of the patient with suspected factitious diarrhea consists
of :
a. measuring stool osmolality
b. performing endoscopy
c. analyzing stool water or urine for laxatives.
a. Measurement of stool osmolality
Can be useful in detecting factitious diarrhea caused by the addition of
water or dilute urine to the stool:
• Because stool osmolality can never be less than that of plasma, a
low osmolality (<290 mOsm/kg) can only result by adding a
hypotonic solution, such as water or urine, to stool
• In addition, a very high stool osmolality (>600 mOsm/kg) may be a
clue to stool diluted with hypertonic solutions, such as tomato juice
or blood
• A stool osmolality of less than 600 mOsm/kg often indicates
prolonged storage and carbohydrate fermentation
Therefore, a measured stool osmolality of less than 290 mOsm/kg or
greater than 600 mOsm/kg is a potential clue to factitious
diarrhea.
b. Colonoscopy
• Pseudo–melanosis coli may be a potential clue found on
colonoscopy ( brownish discoloration of the colonic mucosa caused
by the accumulation of lipofuscin pigment in macrophages of the
lamina propria;
- It occurs with the use of anthraquinone laxatives, such as senna,
cascara, and rhubarb, and takes on average 9 months to develop
- It is benign and reversible, disappearing within 1 year of
discontinuing use of anthraquinone laxatives
- pseudo–melanosis coli is not pathognomonic for anthraquinone
laxative use and may be seen in other conditions that cause chronic
colonic inflammation
- In addition, patients may be unaware that they are ingesting
anthraquinone like laxatives because they may be “natural”
ingredients in herbal teas and other health supplements
stool, urine, and serum can be tested for laxatives.
c. Stool, urine, and serum can be tested for
Acute infectious diarrhea
I. Non-invasive,
non-inflammatory
= secretory
II. Invasive
inflammatory
III. Penetrating enteral
infections of the mucosa
I. Non-invasive = Secretory diarhhea
• Toxigenic diarrhea (consequence of enterotoxin action,
germs remain on the cell surface)
• At the proximal SI level
• ↓ Na absorption, ↑ Cl absorption
→ watery, voluminous diarrhea without leukocytes
→ severe, rapid dehydration
→ V. cholerae, Enterotoxigenic E. Coli, Staph. aureus
→ Cl. perfrigens, B. Cereus
→ Viruses: RotaV, CoronaV, EnteroV, CaliciV
II. Invasive= Inflamatory diarhhea
• At the distal SI and colon :
- ulcerative lesions - direct action of bacterial enterotoxins →
intestinal secretion of water and electrolytes
- local inflammatory changes by prostaglandin hypersynthesis
- intestinal epithelial lesions → ↑ transudation of fluid into the
colon with ↓ absorption
→ Salmonella enteritidis, E. Coli enteroinvasive,
Campylobacter jejuni, Entamoeba histolityca
III. Penetrating enteral infections of
the mucosa
• Multiplication, colonization in RES:
- reduced / absent diarrhea
- fever ↑↑
- bacteremia ↑↑
→ Salmonella typhi, Yersinia enterolitica
Acute diarrhea(< 4 days) typically
doesn’t require testing
Indications for evaluation
• Dehydration/ volume depletion
• hematochezia or blood-tinged stool
• Fever ≥ 38.5˚C
• Duration> 48h without improvement
• Recent antibiotic use
• Associated severe abdominal pain
• Age ≥ 65- 70 years
• Immunocompromised patients
Laboratory exams
• CBC
• Electrolytes
• BUN, creatinine
• Stool samples:
- microscopy
- culture
- fecal leucocyte
- Cl. Difficile toxin assay
Acute diarrhea.pptx

More Related Content

PPT
Diarrhe and how to diagnose it the approach.ppt
PPTX
Diarrheal diseases
PPTX
Diarrheal diseases.pptx
PPTX
9. Diahhreal disease dr. abdikadir hasan.pptx
PPTX
SEMINAR approach to Diarrhea and Constipation.pptx
PPTX
Chronic diarrhea
PPTX
lecture on Acute and Chronic Diarrhoea.pptx
PPTX
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017
Diarrhe and how to diagnose it the approach.ppt
Diarrheal diseases
Diarrheal diseases.pptx
9. Diahhreal disease dr. abdikadir hasan.pptx
SEMINAR approach to Diarrhea and Constipation.pptx
Chronic diarrhea
lecture on Acute and Chronic Diarrhoea.pptx
Acute & Chronic Diarrhea and Constipation: Approach to Management 2 Oct 2017

Similar to Acute diarrhea.pptx (20)

PPT
Diarrhea clinical diagnosis
PDF
Diarrhea & constipation by dr mohammed hussien
PPTX
PPTX
Acute management of acute watery diarrhea
PPTX
DIARRHOES SYNDROME.pptx FROM MEDICINE MBBS
PPTX
Diarrhea, ibs, and malabsorption syndrome
PPTX
Diarrhoea by Dr Peter Soltau 2014
PPTX
Acute infectious diarrhea
PPTX
DIARRHEA (1).pptx
PDF
Acute and chronic diarrhea
DOC
Diarrhea
PPTX
Diarrhea ppt
PPTX
PPT
L 5. approach to diarhea
PDF
diarrheappt-121004140501-phpapp01.pdf
PPTX
Diarrhea ppt
PDF
DIARRHEA pathophysiology and management.
PDF
acute diarrhea.pdf.pdf.hnsndkdkknznnsmsjjs
PPT
Ims diarrhoea-1
Diarrhea clinical diagnosis
Diarrhea & constipation by dr mohammed hussien
Acute management of acute watery diarrhea
DIARRHOES SYNDROME.pptx FROM MEDICINE MBBS
Diarrhea, ibs, and malabsorption syndrome
Diarrhoea by Dr Peter Soltau 2014
Acute infectious diarrhea
DIARRHEA (1).pptx
Acute and chronic diarrhea
Diarrhea
Diarrhea ppt
L 5. approach to diarhea
diarrheappt-121004140501-phpapp01.pdf
Diarrhea ppt
DIARRHEA pathophysiology and management.
acute diarrhea.pdf.pdf.hnsndkdkknznnsmsjjs
Ims diarrhoea-1
Ad

Recently uploaded (20)

PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PPTX
antibiotics rational use of antibiotics.pptx
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPT
HIV lecture final - student.pptfghjjkkejjhhge
PPTX
Post Op complications in general surgery
PDF
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPT
Obstructive sleep apnea in orthodontics treatment
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PPTX
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
PPTX
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
PPTX
the psycho-oncology for psychiatrists pptx
PPTX
Anatomy and physiology of the digestive system
PPTX
CHEM421 - Biochemistry (Chapter 1 - Introduction)
PPTX
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
neurology Member of Royal College of Physicians (MRCP).ppt
nephrology MRCP - Member of Royal College of Physicians ppt
antibiotics rational use of antibiotics.pptx
vertigo topics for undergraduate ,mbbs/md/fcps
PEADIATRICS NOTES.docx lecture notes for medical students
شيت_عطا_0000000000000000000000000000.pdf
HIV lecture final - student.pptfghjjkkejjhhge
Post Op complications in general surgery
Extended-Expanded-role-of-Nurses.pdf is a key for student Nurses
Acute Coronary Syndrome for Cardiology Conference
Obstructive sleep apnea in orthodontics treatment
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
ANATOMY OF MEDULLA OBLANGATA AND SYNDROMES.pptx
NASO ALVEOLAR MOULDNIG IN CLEFT LIP AND PALATE PATIENT
the psycho-oncology for psychiatrists pptx
Anatomy and physiology of the digestive system
CHEM421 - Biochemistry (Chapter 1 - Introduction)
MANAGEMENT SNAKE BITE IN THE TROPICALS.pptx
Rheumatology Member of Royal College of Physicians.ppt
MENTAL HEALTH - NOTES.ppt for nursing students
Ad

Acute diarrhea.pptx

  • 1. Acute diarrhea Cristina Olariu, MD, PhD Assistant Professor at University of Medicine and Pharmacy Carol Davila National Institute for Infectious Diseases “Prof. Dr. Matei Bals”
  • 2. Agenda • Definitions, pathophysiological mechanisms • Diagnostic strategies • Diagnostic algorithm
  • 3. Definition = increased stool frequency, liquidity or volume 1increase in stool frequency; 2passage of loose stools. 3Diarrhea is objectively defined as passing a stool weight or volume greater than 200 g or 200 mL per 24 hours. • Diarrhea is a major cause of morbidity. It is important to recognize that diarrhea is a symptom or sign, not a disease, and can be caused by numerous conditions. • An understanding of the basic mechanisms of diarrhea can help facilitate diagnosis and management.
  • 4. Defense mechanisms 1. Gastric acid secretion (pH < 4 → > 90% of bacteria are destroyed in one hour) 2. Normal enteric flora - superior IS (alkaline pH, richly vascularized mucosa) → systemic absorption of toxins (enterococci, BGN) - terminal ileum, colon (> 99% anaerobic flora, species specificity, individual, stable) 1. Gastrointestinal and colonic motility (eg Shigella and Salmonella treated with antidiarrheals → worsening) 2. Phagocytosis and humoral and cellular immunity 3. Other defense mechanisms: - genetic determinants - infants: lactoferrin, lysozyme, oligosaccharides
  • 5. Pathogenic mechanisms 1. Inoculum size 2. Accelerating intestinal transit 3. Adhesion of bacteria to the intestinal mucosa 4. The ability to "invade" the intestinal mucosa 5. Toxin production: - endotoxins (lipopolysaccharides) - exotoxins (polypeptides) 6. Bacterial translocation
  • 6. 1. Size of inoculum • 10-100 bacteria / cysts - Shigella, E. Coli, G. Lamblia, Entamoeba hystolitica; - direct contact, person to person • 105- 108- V. cholerae
  • 7. 2. Accelerating intestinal transit → Reduces contact time with the intestinal mucosa → Cancels the dominance of colonic anaerobes Causes secretory and osmotic diarrhea *Slowing of intestinal transit → Secretory D. by SIBO
  • 8. 3. Adhesion of bacteria to the intestinal mucosa • Adhesion factors = plasmidally encoded Ag • Fimbrii, pili, flageli • Microbial molecules involved in adhesion and fixation - adhesives
  • 9. 4. The ability to invade the intestinal mucosa = Synthesis (plasmid coding) of: - adhesins - cytotoxic exotoxins (Shigella, Cl., Staf) - integrins → survival and multiplication of germs in the intestinal epithelial cells (Salmonella, Shigella)
  • 10. Toxin production Enterotoxins Cytotoxins Neurotoxins Secretory = watery D. Toxin of V. cholerae Enterotoxigenic E.coli : - heat labile enterotoxins (LT) - heat-stable enterotoxins (ST) Infectious D Staf. aureus Bacillus cereus Shigella dysentarie tip 1 Vibrio parahaemolyticus Cl. Difficile E.Coli enterohemoragică
  • 11. 5. Bacterial translocation • the bacterial passage from the intestinal lumen • passage of endotoxins through the intact intestinal barrier Intestinal barrier: → extrinsic: mucus, IgA, intestinal flora → intrinsic: - transcellular (intestinal cells) - paracellular ("tight" junction)
  • 12. Pathophysiology Incomplete absorption of water from intestinal luminal contents • Water itself is not actively transported across the intestinal mucosa but moves across secondary to osmotic forces generated by the transport of solutes, such as electrolytes and nutrients. • Normally, absorption and secretion take place simultaneously, but absorption is quantitatively greater Either a decrease in absorption or an increase in secretion leads to additional water within the lumen and diarrhea(Excess stool water then causes decreased stool consistency)
  • 13. Normally, SI and LI absorb 99% of the fluids. Therefore, even a very small reduction (eg 1%) in absorption or an increase in secretion causes an increase in water content sufficient to cause diarrhea.
  • 14. Pathophysiologic mechanisms • Osmotic diarrhea = involves an unabsorbed substance that draws water from the plasma into the intestinal lumen along osmotic gradients • Secretory diarrhea = results from disordered electrolyte transport and, despite the term, is more commonly caused by decreased absorption rather than net secretion. • Inflammatory Inflammatory diseases cause diarrhea with exudative, secretory, or osmotic components • Altered motility = may alter fluid absorption by increasing or decreasing the exposure of luminal content to intestinal absorptive surface. However, from a pathophysiologic perspective, no single cause of diarrhea is truly unifactorial.
  • 15. Diagnostic strategy An understanding of the epidemiological settings in which diarrhea occurs (eg, community acquired, hospital acquired, or travel related) will also help direct diagnosis and treatment. Physical examination Detailed history
  • 16. Simplified 5-Step Approach 1. Does the patient really have diarrhea? Beware of fecal incontinence and impaction! 2. Rule out medications as a cause of diarrhea (drug- induced diarrhea). 3. Distinguish acute from chronic diarrhea. 4. Categorize the diarrhea as inflammatory, fatty, or watery. 5. Consider factitious diarrhea
  • 17. 1. Does the Patient Really Have Diarrhea? Beware of Fecal Incontinence and Impaction • Fecal incontinence is often reported as diarrhea because of embarrassment associated with this condition rather than because the patient has any real difficulty distinguishing diarrhea from incontinence - direct questioning and assessment of anal squeeze on digital examination! Incontinence is defined as the involuntary release of rectal contents; continence requires intact anorectal structure and neuromuscular function; although many incontinent patients have loose stools, their predominant problem is anal sphincter dysfunction and not dysregulated intestinal fluid or electrolyte absorption If fecal incontinence is frequent, especially if it occurs in the absence of rectal urgency or loose stools, the patient should be evaluated for incontinence and not diarrhea. • Fecal impaction - Patients with chronic constipation may develop fecal impaction from the inability to expel a large fecal mass through the anus; rectal distention causes relaxation of the internal anal sphincter, and there is induction of secretions proximal to the obstructing stool→ An overflow diarrhea results from liquid stool passing around the impaction and may be reported as diarrhea - A careful rectal examination will allow identification and treatment of this condition.
  • 18. 2. Rule Out Medications as a Cause of Diarrhea (Drug-Induced Diarrhea) The key to diagnosing drug-induced diarrhea is to establish the temporal relationship between starting use of the drug and onset of diarrhea • The medications that most frequently cause diarrhea: - antacids and nutritional supplements that contain magnesium - antibiotics - proton pump inhibitors - selective serotonin reuptake inhibitors - nonsteroidal anti-inflammatory drugs.
  • 19. 2. Drug-induced diarrhea • activation of specific receptors and transporters • alteration in colonic bacterial flora • changes in mesenteric blood flow • provocation of intestinal inflammation • apoptotic enteropathy • Caffeine is an agent that may cause increased intestinal fluid secretion by elevating intracellular cyclic adenosine monophosphate levels • Antibiotics alter colonic bacterial flora that may then decrease colonic bacterial fermentation of malabsorbed carbohydrates or lead to Clostridium difficile infection • Mesenteric vasoconstricting agents may decrease mesenteric blood flow and cause malabsorption • Nonsteroidal anti-inflammatory drugs or mycophenolate mofetil are agents that may incite intestinal inflammation, causing diarrhea • chemotherapy may cause intestinal or colonic crypt damage, thus impairing water absorption and resulting in an apoptotic enterocolopathy To identify drug-induced diarrhea, it is imperative that the physician take a complete medication history and inquire about over-the-counter medications and supplements (eg, vitamin C and magnesium). Treatment involves withdrawal of the offending drug.
  • 20. 3. Distinguish acute from chronic diarrhea • acute if it lasts fewer than 2 weeks it is most commonly caused by infection and is self-limited often, no evaluation or treatment is required. • chronic if it lasts more than 4 weeks • stool testing and other studies are often indicated in the presence of certain clinical or epidemiological features, including age older than 65 years, immune compromise, volume depletion, hematochezia or blood-tinged stool, fever, severe abdominal pain, recent antibiotic use, known or suspected inflammatory bowel disease, community infectious disease outbreaks, and employment as a food handler. In contrast to acute diarrhea, chronic diarrhea typically warrants a diagnostic evaluation, is less likely to resolve on its own, and presents a broad differential diagnosis.
  • 21. Epidemiological features • Traveler’s diarrhea: - bacterial infections; - parasitosis - tropical sprue • Epidemics: - bacterial infections; - viral infections; - inf. with protozoa (Cryptosporidium) - idiopathic epidemic secretory diarrhea • Patients with HIV / AIDS: - opportunistic infections (CMV, Mycobacterium avium) - AE of ARV medication - lymphoma • Institutionalized patients: - colitis with Cl. Difficile - intoxications / drug RA / artificial feeding / false diarrhea • Patients with diabetes: - impaired motility - AE of medication (Metformin) - associated diseases (celiac disease, exocrine pancreatic insufficiency)
  • 22. Indications for evaluation • Dehydration/ volume depletion • hematochezia or blood-tinged stool • Fever ≥ 38.5˚C • Duration> 48h without improvement • Recent antibiotic use • Associated severe abdominal pain • Age ≥ 65- 70 years • Immunocompromised patients
  • 23. Categorization of diarrhea. CT = computed tomography; EUS = endoscopic ultrasonography; SIBO = small intestinal bacterial overgrowth. 4. Categorize the diarrhea as inflammatory, fatty, or watery
  • 24. Inflammatory diarrhea • frequent, small-volume, bloody stools and may be accompanied by tenesmus, fever, or severe abdominal pain • leukocytes or leukocyte proteins (eg, calprotectin or lactoferrin) on stool examination • elevated C-reactive protein level or sedimentation rate and low serum albumin level Inflammatory diarrhea fundamentally indicates disrupted and inflamed mucosa: - idiopathic inflammatory bowel disease (Crohn disease or ulcerative colitis) - ischemic colitis - infectious processes, such as C difficile, cytomegalovirus, tuberculosis, or Entamoeba histolytica - Radiation colitis and neoplasia When history or stool analysis suggests chronic inflammatory diarrhea, flexible sigmoidoscopy or colonoscopy should be the initial study to look for structural changes.
  • 25. Fatty stools • weight loss, greasy or bulky stools that are difficult to flush, and oil in the toilet bowl that requires a brush to remove • The basic mechanisms of chronic fatty diarrhea are malabsorption and maldigestion; - Fat malabsorption results from inadequate mucosal transport; - Fat maldigestion results from defective hydrolysis of triglycerides Malabsorption is caused by mucosal diseases, most commonly celiac disease, whereas the maldigestion results from pancreatic exocrine insufficiency (eg, chronic pancreatitis) or inadequate duodenal bile acid concentration (eg, small intestinal bacterial overgrowth [SIBO] or cirrhosis) A simple test to screen for excess fecal fat is a Sudan stain, which will detect most cases of clinically significant steatorrhea. However, the criterion standard for steatorrhea is a quantitative measurement on a timed stool collection while patients consume a 100-g fat diet, and steatorrhea is defined as more than 7 g of fat per 24 hours. When fatty diarrhea is identified, the initial goal is to distinguish malabsorption from maldigestion - Endoscopy with small bowel biopsies allows evaluation of the small intestinal mucosa for celiac disease. - Small bowel aspiration can be performed to look for SIBO, which causes steatorrhea by deconjugation of bile acids with resultant low duodenal bile acid concentrations. In addition, - Hydrogen breath tests may be used to diagnose SIBO The diagnosis of SIBO requires consideration of a predisposing factor, such as intestinal stasis, achlorhydria, pancreatic insufficiency, or immune deficiency If small bowel disease is excluded, computed tomography or endoscopic ultrasonography may be useful to identify morphological changes of chronic pancreatitis If no intestinal abnormalities are found and there is no evidence of chronic pancreatitis, abnormal pancreatic exocrine function should be considered. An empiric trial of pancreatic enzyme supplementation may be used to assess for the presence of pancreatic exocrine insufficiency - high doses of enzymes should be prescribed, and some objective measurement, such as fecal fat excretion or weight gain, should be monitored to assess response
  • 26. Watery diarrhea→ osmotic or secretory in origin • Osmotic diarrhea is due to the ingestion of poorly absorbed ions or sugars • Secretory diarrhea is due to disruption of epithelial electrolyte transport. Two ways to distinguish an osmotic from a secretory process is by response to fasting and calculating the fecal osmotic gap: - An essential characteristic of osmotic diarrhea is that stool volume decreases with fasting, whereas secretory diarrhea typically continues unabated with fasting - Another way to clinically differentiate osmotic diarrhea from secretory diarrhea is by calculating the fecal osmotic gap: • A fecal osmotic gap greater than 50 mmol/L suggests an osmotic cause for diarrhea • A gap less than 50 mmol/L supports a secretory origin
  • 28. Osmotic diarrhea • poorly absorbed cations (eg, magnesium) or anions (eg, phosphate, or sulfate)↔laxatives and antacids • carbohydrate malabsorption from ingestion of poorly absorbed sugars or sugar alcohols (eg, sorbitol or xylitol) • Lactose intolerance is by far the most common type of carbohydrate malabsorption, with prevalence rates up to 100% in Africa, Asia, and Latin America Measuring a stool pH can help distinguish between osmotic diarrhea due to poorly absorbed ions and that due to poorly absorbed sugars
  • 29. • Carbohydrate malabsorption will result in a stool pH less than 6 because as carbohydrates reach the colon they are fermented by bacteria, releasing short-chain fatty acids and making the stool water acidic • Lactase is present in IS in most young, immature mammals but decreases or disappears at adulthood →70% of adults have lactase deficiency
  • 30. • The basic pathophysiologic mechanism involves either net secretion of ions (chloride or bicarbonate) or inhibition of net sodium absorption • The most common cause of secretory diarrhea is infectious; however, infection is an uncommon cause of chronic secretory diarrhea. Therefore, noninfectious causes of secretory diarrhea should be sought.
  • 31. Major Causes of Secretory Diarrhea • Infection • Bile acid malabsorption • Nonosmotic laxatives • Inflammatory bowel disease (microscopic colitis, Crohn disease, ulcerative colitis) • Disordered regulation (eg, post vagatomy, diabetic neuropathy) • Peptide-secreting endocrine tumors • Neoplasia (colon carcinoma, lymphoma, villous adenoma) • Idiopathic or epidemic secretory diarrhea
  • 32. Tumor Associated findings Gastrinoma Abdominal pain, erosive esophagitis, enlarged gastric folds, duodenal ulcers Carcinoid Flushing, enlarged nodular liver from metastases VIPoma Hypokalemia, achlorhydria Somatostatinoma Diabetes mellitus, cholelithiasis, hypochlorhydria Glucagonoma Diabetes mellitus, deep vein thrombosis, depression, necrolytic migratory erythema Endocrine Neoplasms Associated With Diarrhea
  • 33. 5. Consider Factitious Diarrhea • Factitious diarrhea is an intentionally self-inflicted disorder. The most frequent cause of factitious diarrhea is surreptitious laxative ingestion(up to 15% of patients who undergo an evaluation for chronic diarrhea may be surreptitiously ingesting laxatives) • Individuals with factitious diarrhea are most commonly women of higher socioeconomic status and often employed in the medical field. There is frequently a history of multiple medical consultations or hospitalizations in an effort to establish the cause of diarrhea • Evaluation of the patient with suspected factitious diarrhea consists of : a. measuring stool osmolality b. performing endoscopy c. analyzing stool water or urine for laxatives.
  • 34. a. Measurement of stool osmolality Can be useful in detecting factitious diarrhea caused by the addition of water or dilute urine to the stool: • Because stool osmolality can never be less than that of plasma, a low osmolality (<290 mOsm/kg) can only result by adding a hypotonic solution, such as water or urine, to stool • In addition, a very high stool osmolality (>600 mOsm/kg) may be a clue to stool diluted with hypertonic solutions, such as tomato juice or blood • A stool osmolality of less than 600 mOsm/kg often indicates prolonged storage and carbohydrate fermentation Therefore, a measured stool osmolality of less than 290 mOsm/kg or greater than 600 mOsm/kg is a potential clue to factitious diarrhea.
  • 35. b. Colonoscopy • Pseudo–melanosis coli may be a potential clue found on colonoscopy ( brownish discoloration of the colonic mucosa caused by the accumulation of lipofuscin pigment in macrophages of the lamina propria; - It occurs with the use of anthraquinone laxatives, such as senna, cascara, and rhubarb, and takes on average 9 months to develop - It is benign and reversible, disappearing within 1 year of discontinuing use of anthraquinone laxatives - pseudo–melanosis coli is not pathognomonic for anthraquinone laxative use and may be seen in other conditions that cause chronic colonic inflammation - In addition, patients may be unaware that they are ingesting anthraquinone like laxatives because they may be “natural” ingredients in herbal teas and other health supplements stool, urine, and serum can be tested for laxatives. c. Stool, urine, and serum can be tested for
  • 36. Acute infectious diarrhea I. Non-invasive, non-inflammatory = secretory II. Invasive inflammatory III. Penetrating enteral infections of the mucosa
  • 37. I. Non-invasive = Secretory diarhhea • Toxigenic diarrhea (consequence of enterotoxin action, germs remain on the cell surface) • At the proximal SI level • ↓ Na absorption, ↑ Cl absorption → watery, voluminous diarrhea without leukocytes → severe, rapid dehydration → V. cholerae, Enterotoxigenic E. Coli, Staph. aureus → Cl. perfrigens, B. Cereus → Viruses: RotaV, CoronaV, EnteroV, CaliciV
  • 38. II. Invasive= Inflamatory diarhhea • At the distal SI and colon : - ulcerative lesions - direct action of bacterial enterotoxins → intestinal secretion of water and electrolytes - local inflammatory changes by prostaglandin hypersynthesis - intestinal epithelial lesions → ↑ transudation of fluid into the colon with ↓ absorption → Salmonella enteritidis, E. Coli enteroinvasive, Campylobacter jejuni, Entamoeba histolityca
  • 39. III. Penetrating enteral infections of the mucosa • Multiplication, colonization in RES: - reduced / absent diarrhea - fever ↑↑ - bacteremia ↑↑ → Salmonella typhi, Yersinia enterolitica
  • 40. Acute diarrhea(< 4 days) typically doesn’t require testing
  • 41. Indications for evaluation • Dehydration/ volume depletion • hematochezia or blood-tinged stool • Fever ≥ 38.5˚C • Duration> 48h without improvement • Recent antibiotic use • Associated severe abdominal pain • Age ≥ 65- 70 years • Immunocompromised patients
  • 42. Laboratory exams • CBC • Electrolytes • BUN, creatinine • Stool samples: - microscopy - culture - fecal leucocyte - Cl. Difficile toxin assay